Summit Therapeutics says cash crunch could impact its ability to continue
· seekingalpha.com
Summit Therapeutics warns cash may not last 12 months, raising going concern risk. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...